Chemotherapy-induced nausea and vomiting in acute leukemia and stem cell transplant patients: results of a multicenter, observational study.

Javier López‐Jiménez(Hospital Universitario Ramón y Cajal), Gonzalo Fernández, Eva Martín-Ballesteros, Carla Uralburu, Daniel García‐Belmonte, Cristina Fernández, Anna Sureda(Institut d'Investigació Biomédica de Bellvitge), Ignacio Lorenzo, María Calbacho(Hospital Universitario 12 De Octubre), Raquel Del Campo
PubMed
January 1, 2006
Cited by 56

Related Papers

Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma
|New England Journal of Medicine|2021|1.6k
Brentuximab vedotin as consolidation therapy after autologous stem-cell transplantation in patients with Hodgkin's lymphoma at risk of relapse or progression (AETHERA): a randomised, double-blind, placebo-controlled, phase 3 trial
|The Lancet|2015|740
Glofitamab for Relapsed or Refractory Diffuse Large B-Cell Lymphoma
|New England Journal of Medicine|2022|718
Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma
|New England Journal of Medicine|2023|538
Second-Line Tisagenlecleucel or Standard Care in Aggressive B-Cell Lymphoma
|New England Journal of Medicine|2021|532